AMAG is a pharmaceutical company focused on bringing innovative products to patients with unmet medical needs across a range of therapeutic areas, including women’s health, all while delivering value to our shareholders.

Headquartered in Waltham, Massachusetts, we develop and deliver innovative medicines for complex yet under-treated health conditions across a range of therapeutic areas including anemia, pregnancy complications, women’s sexual function and menopause-related issues. We also work with patients and healthcare experts to break down barriers to care for the communities we serve through focused education and support programs.”

As we have grown, we have continued to invest in promising therapies at various stages of development and advance them through the clinical and regulatory process to deliver new treatment options to patients.


  AMAG 2Q2018 Financial Results

2017 Form 10-K and 2018 Proxy Materials

  View the 10-K
  View the Proxy
  View the Proxy Card
  View the Shareholder Letter

Recent Event Webcasts

Webcast ImageWebcast
Q2 2018 AMAG Pharmaceuticals, Inc. Earnings Conference Call (Replay)
August 02, 2018 at 8:00 a.m. ET